BlackRock Fund Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

BlackRock Fund Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22K	Buy	5,277 +1,061	+25%	+$4.4K	﹤0.01%	3875
2016 Q3	$16K	Sell	4,216 -3,790	-47%	-$13.8K	﹤0.01%	3905
2016 Q2	$27K	Sell	8,006 -596,356	-99%	-$2.74M	﹤0.01%	3885
2016 Q1	$3.21M	Buy	604,362 +27,753	+5%	+$222K	﹤0.01%	2938
2015 Q4	$7.09M	Buy	576,609 +147,586	+34%	+$1.97M	﹤0.01%	2649
2015 Q3	$6.26M	Buy	429,023 +5,029	+1%	+$86.9K	﹤0.01%	2667
2015 Q2	$8.27M	Buy	423,994 +4,224	+1%	+$81.5K	﹤0.01%	2616
2015 Q1	$7.6M	Buy	419,770 +3,376	+0.8%	+$76K	﹤0.01%	2601
2014 Q4	$9.83M	Buy	416,394 +91,123	+28%	+$2.11M	﹤0.01%	2469
2014 Q3	$7.87M	Sell	325,271 -10,288	-3%	-$267K	﹤0.01%	2493
2014 Q2	$9.43M	Sell	335,559 -26,044	-7%	-$783K	﹤0.01%	2457
2014 Q1	$12.3M	Buy	361,603 +13,517	+4%	+$462K	﹤0.01%	2280
2013 Q4	$6.65M	Buy	348,086 +30,549	+10%	+$556K	﹤0.01%	2635
2013 Q3	$5.15M	Buy	317,537 +36,810	+13%	+$427K	﹤0.01%	2798
2013 Q2	$2.95M	Buy	+280,727	New	+$3.29M	﹤0.01%	2998

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

BlackRock Fund Advisors's CTIC Position: Q4 2016 in Review

BlackRock Fund Advisors increased its CTI BioPharma Corp. (DE) Common Stock (CTIC) stake by 25% in Q4 2016, buying an estimated $4.4K and bringing the position to 5,277 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #3875.

BlackRock Fund Advisors first reported a position in CTIC in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.3M in Q1 2014. 58 funds tracked by Wall St. Rank hold CTIC as of Q4 2016.

BlackRock Fund Advisors held 5,277 shares of CTI BioPharma Corp. (DE) Common Stock worth $22K as of Q4 2016.
BlackRock Fund Advisors bought 1,061 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2016, an estimated $4.4K.
CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3875 holding.
BlackRock Fund Advisors first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's CTI BioPharma Corp. (DE) Common Stock position peaked at $12.3M in Q1 2014.
58 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.